HomeDAITF • OTCMKTS
add
Daito Pharmaceutical Co Ltd
Previous close
$6.57
Market cap
40.93B JPY
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
In the news
Financials
Income Statement
Revenue
Net income
| (JPY) | Nov 2025info | Y/Y change |
|---|---|---|
Revenue | 12.13B | 1.88% |
Operating expense | 1.58B | 4.84% |
Net income | 537.00M | 85.17% |
Net profit margin | 4.43 | 81.56% |
Earnings per share | — | — |
EBITDA | 1.69B | 1.11% |
Effective tax rate | 30.31% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Nov 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.22B | -31.38% |
Total assets | 76.84B | -3.50% |
Total liabilities | 24.64B | -10.77% |
Total equity | 52.20B | — |
Shares outstanding | 29.58M | — |
Price to book | 0.00 | — |
Return on assets | 2.01% | — |
Return on capital | 2.46% | — |
Cash Flow
Net change in cash
| (JPY) | Nov 2025info | Y/Y change |
|---|---|---|
Net income | 537.00M | 85.17% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Jun 30, 1942
Website
Employees
1,073
